Who needs venture backers? Bill Haney bags new deal cash from Celgene as his biotech upstart Dragonfly explores NK cell tech
Bill Haney continues to build Dragonfly Therapeutics one deal at a time. And now he’s banking more cash as he grows the company into an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
